Search

everythinglearnresearchcommunity

for

Search:↓

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

High levels of HSP70 and IL-15 are linked to more severe alopecia areata.

Lower hair copper and copper-to-zinc ratio are linked to more severe coronary artery disease.

Oxidative stress may worsen female pattern hair loss and could help track the disease and treatment.

Finasteride may cause depression and suicidal thoughts, especially in young men.

Metal nanoparticles show promise for treating hair loss but need more research to ensure safety.

Ongoing monitoring and treatment are crucial to manage sarcoptic mange in reintroduced red foxes.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Trichoscopy is better than the hair pull test for tracking alopecia areata.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Tofacitinib is an effective and safe treatment for alopecia areata.

Intralesional Triamcinolone acetonide injections are safe and effective for treating alopecia areata.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Melatonin may help with atopic dermatitis by reducing inflammation and improving sleep.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Hyaluronic acid injections can improve mouth opening and quality of life in scleroderma patients.

Intralesional methotrexate and triamcinolone acetonide are more effective than Vitamin D3 for treating alopecia areata.